» Articles » PMID: 37167978

Advances in Mapping Tumor Progression from Precancer Atlases

Overview
Specialty Oncology
Date 2023 May 11
PMID 37167978
Authors
Affiliations
Soon will be listed here.
Abstract

Tissue profiling technologies present opportunities for understanding transition from precancerous lesions to malignancy, which may impact risk stratification, prevention, and even cancer treatment. A human precancer atlas building effort is ongoing to tackle the significant challenge of decoding the heterogeneity among cells, specimens, and patients. Here, we discuss the findings resulting from atlases built across precancer types, including those found in colon, breast, lung, stomach, cervix, and skin, using bulk, single-cell, and spatial profiling strategies. We highlight two main themes that emerge across precancer types: the ordering of molecular events that occur during tumor progression and the fluctuation of microenvironmental response during precancer progression. We further highlight the key challenges of data integration across large cohorts of patients, and the need for computational tools to reliably annotate and quality control high-volume, high-dimensional data.

Citing Articles

Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.

Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y Signal Transduct Target Ther. 2024; 9(1):149.

PMID: 38890350 PMC: 11189549. DOI: 10.1038/s41392-024-01848-7.


The Hallmarks of Precancer.

Stangis M, Chen Z, Min J, Glass S, Jackson J, Radyk M Cancer Discov. 2024; 14(4):683-689.

PMID: 38571435 PMC: 11170686. DOI: 10.1158/2159-8290.CD-23-1550.

References
1.
Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View

2.
Parsons D, Jones S, Zhang X, Cheng-Ho Lin J, Leary R, Angenendt P . An integrated genomic analysis of human glioblastoma multiforme. Science. 2008; 321(5897):1807-12. PMC: 2820389. DOI: 10.1126/science.1164382. View

3.
Kriegl L, Neumann J, Vieth M, Greten F, Reu S, Jung A . Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. Mod Pathol. 2011; 24(7):1015-22. DOI: 10.1038/modpathol.2011.43. View

4.
Dagogo-Jack I, Shaw A . Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol. 2017; 15(2):81-94. DOI: 10.1038/nrclinonc.2017.166. View

5.
Kunz M, Loffler-Wirth H, Dannemann M, Willscher E, Doose G, Kelso J . RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas. Oncogene. 2018; 37(47):6136-6151. DOI: 10.1038/s41388-018-0385-y. View